Funding round
ITM Radiopharma Growth
Reported as "Growth Equity"
ITM Radiopharma, which works in radiopharmaceutical development and manufacturing in Garching bei München, raised $205M in a Growth round announced on 1 Jan 2024, led by Temasek. 5 firms took part.
$205M
Amount raised
Not disclosed
Post-money valuation
5
Investors
1 lead
Valuation
What this round says about the price
ITM Radiopharma did not disclose a valuation in this round. It is ITM Radiopharma's first venture round on record, 20 years after it was founded in 2004. No later venture round is on record for ITM Radiopharma.
ITM Radiopharma's funding rounds
This is the only venture round on record for ITM Radiopharma.
- Debt not a venture round 22 Apr 2021, led by Petrichor $109M
- Growth this round 1 Jan 2024, led by Temasek $205M
- Debt not a venture round 27 May 2025, led by Blue Owl Capital $263M
Investors
Who put money in
Temasek led the round with 4 other firms.
Lead investor
- Temasek backs 195 venture-backed companies new investor
Also in the round
- BlackRock new investor
- Qatar Investment Authority backs 71 venture-backed companies new investor
- backs 19 venture-backed companies new investor
- Carbyne new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development.
- Product development
Comparable rounds
How it compares
28 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $52M, and this round was 3.9 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 3 Jan 2024 | $60M | not disclosed | The Column Group |
| Pharmaceutical Products | 19 Jan 2024 | $26M | not disclosed | not named |
| Pharmaceutical Products | 28 Mar 2024 | $50M | not disclosed | Hevolution |
| Pharmaceutical Products | 5 Mar 2024 | $45M | not disclosed | NewVale Capital |
| Pharmaceutical Products | 2 Nov 2023 | $19M | not disclosed | Ampersand Capital Partners |
| Pharmaceutical Products | 4 Apr 2024 | $34M | not disclosed | not named |
| Pharmaceutical Products | 16 Apr 2024 | $26M | not disclosed | not named |
| Pharmaceutical Products | 17 Apr 2024 | $21M | not disclosed | Signet Healthcare Partners |
Sources
Where this comes from
Reported by 5 sources.
Questions
Frequently asked
How much did ITM Radiopharma raise in its Growth round?
ITM Radiopharma raised $205M in its Growth round, announced in Jan 2024.
Who led ITM Radiopharma's Growth round?
Temasek led it, with BlackRock, Qatar Investment Authority, Athos Capital and Carbyne.
What was ITM Radiopharma's valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
28 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $52M, and this round was 3.9 times the median.